Novacept
This article was originally published in Start Up
Executive Summary
Gynecological Devices; Endometrial Ablation. Novacept feels its device for endometrial ablation will be easy for Ob/Gyns to use in an office setting. The device consistently tailors the ablation depth to the region of the uterus in which it is working,stops automatically once tissue has been properly ablated, and simply requires a physician to squeeze a trigger.
You may also be interested in...
Building Interventional Gynecology
Once a sluggish category for clinical innovation, gynecology is drawing new venture-backed companies eager to build upon the lead created by first-generation companies operating in minimally-invasive endometrial ablation and female sterilization. First generation companies had the difficult task of creating paths to early adopters of minimally invasive procedures. These now exist, and the clinical specialty appears to be also evolving in ways that encourage the growth of in-office procedures.
Novacept: A Patient Device Exit Strategy Succeeds
Using an aggressive clinical trials strategy to overcome early setbacks, Novacept is proof a small company can succeed in a big company market, and that a patient exit strategy can pay off for device companies--evidenced by Cytyc's $325 million cash acquisition of Novacept.
Novacept: A Patient Device Exit Strategy Succeeds
Using an aggressive clinical trials strategy to overcome early setbacks, Novacept is proof a small company can succeed in a big company market, and that a patient exit strategy can pay off for device companies--evidenced by Cytyc's $325 million cash acquisition of Novacept.